Tues: Updates/Deals of the day-mergers and acquisitions **[b]HSP Hospira to buy Orchid generic injectable business[/b] NEW YORK, Dec 15 (Reuters) - Hospira Inc (HSP.N) said on Tuesday that it would buy Orchid Chemicals &
Pharmaceuticals Ltd's (ORCD.BO) generic injectable drug business for $400 million in a deal that will expand its global reach and position as the market leader. The deal includes...